New England Research & Management, Inc. Albemarle Corp Transaction History

New England Research & Management, Inc.

$213 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$162.63 - $243.44 $92,373 - $138,273	-568 Reduced 10.57%	4,808 $818,000
Q2 2023 Jul 05, 2023	BUY	$172.91 - $232.22 $174,639 - $234,542	1,010 Added 23.13%	5,376 $1.2 Million
Q1 2023 Apr 06, 2023	BUY	$208.49 - $290.15 $352,556 - $490,643	1,691 Added 63.21%	4,366 $965,000
Q4 2022 Jan 09, 2023	BUY	$214.02 - $325.38 $572,503 - $870,391	2,675 New	2,675 $580,000
Q2 2022 Jul 20, 2022	BUY	$187.76 - $270.92 $370,826 - $535,067	1,975 Added 89.77%	4,175 $872,000
Q1 2022 Apr 20, 2022	SELL	$172.09 - $246.0 $77,440 - $110,700	-450 Reduced 16.98%	2,200 $487,000
Q4 2021 Jan 05, 2022	SELL	$214.16 - $283.8 $5,354 - $7,095	-25 Reduced 0.93%	2,650 $619,000
Q3 2021 Oct 08, 2021	SELL	$167.91 - $244.03 $386,193 - $561,269	-2,300 Reduced 46.23%	2,675 $586,000
Q2 2021 Jul 15, 2021	BUY	$143.7 - $176.01 $714,907 - $875,649	4,975 New	4,975 $838,000
Q3 2020 Oct 08, 2020	SELL	$75.75 - $100.45 $795,375 - $1.05 Million	-10,500 Closed	0 $0
Q2 2020 Jul 15, 2020	SELL	$52.7 - $86.74 $50,065 - $82,403	-950 Reduced 8.3%	10,500 $811,000
Q1 2020 Jun 15, 2020	BUY	$50.9 - $94.31 $582,805 - $1.08 Million	11,450 New	11,450 $645,000
Q3 2019 Nov 04, 2019	SELL	$59.3 - $75.53 $189,760 - $241,696	-3,200 Closed	0 $0
Q2 2019 Jul 09, 2019	SELL	$63.3 - $86.94 $117,105 - $160,839	-1,850 Reduced 36.63%	3,200 $225,000
Q1 2019 Apr 03, 2019	SELL	$72.69 - $92.28 $3,634 - $4,614	-50 Reduced 0.98%	5,050 $414,000
Q4 2018 Jan 11, 2019	BUY	$73.13 - $107.99 $372,963 - $550,749	5,100 New	5,100 $393,000
Q3 2018 Oct 03, 2018	SELL	$90.9 - $106.6 $454,500 - $533,000	-5,000 Closed	0 $0
Q2 2018 Jul 05, 2018	SELL	$88.96 - $104.92 $40,032 - $47,214	-450 Reduced 8.26%	5,000 $472,000
Q1 2018 Apr 17, 2018	BUY	$89.56 - $137.45 $488,102 - $749,102	5,450 New	5,450 $505,000

Others Institutions Holding ALB

# of Institutions

928

Shares Held

104M

Call Options Held

8.36M

Put Options Held

14.3M

Vanguard Group Inc Valley Forge, PA

14.2M
Shares

$1.54 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

9.96M
Shares

$1.08 Billion
0.02% of portfolio
State Street Corp Boston, MA

6.56M
Shares

$711 Million
0.03% of portfolio
Capital World Investors Los Angeles, CA

6.4M
Shares

$693 Million
0.1% of portfolio
Primecap Management CO Pasadena, CA

3.83M
Shares

$416 Million
0.27% of portfolio

View Full List

About ALBEMARLE CORP

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $12.7B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

More about ALB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Research & Management, Inc. with notifications on news.

Account